Varex Imaging(US:VREX)2021-08-04 01:57Q3 FY21 Financial Performance - Revenue reached $211 million[9] - Non-GAAP gross margin was 36%[10] - Non-GAAP EPS was $0.40[10] - Cash reserves totaled $128 million[10] Revenue Trends and Mix - Medical segment revenue was $167 million[20] - Industrial segment revenue was $44 million[20] - Revenue distribution by region: Americas $66 million, EMEA $76 million, and APAC $69 million[22] China Market - FY21 revenues from China are expected to exceed $100 million[15] - Over half of China revenues are from Medical Tubes[15] Q4 FY21 Outlook (Non-GAAP) - Revenue is projected to be between $205 million and $225 million[35] - EPS is expected to be between $0.25 and $0.40[35] - Gross margin is anticipated to be between 35% and 36%[37] - Operating expenses are estimated to be between $46 million and $47 million[37]